nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—HTR2C—metabolic syndrome X	0.693	1	CbGaD
Trifluoperazine—CALM1—sympathetic nervous system—metabolic syndrome X	0.00872	0.0734	CbGeAlD
Trifluoperazine—HTR2A—arteriole—metabolic syndrome X	0.00833	0.0702	CbGeAlD
Trifluoperazine—CALM1—autonomic nervous system—metabolic syndrome X	0.00586	0.0493	CbGeAlD
Trifluoperazine—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00531	0.0447	CbGeAlD
Trifluoperazine—EBPL—adipose tissue—metabolic syndrome X	0.0045	0.0379	CbGeAlD
Trifluoperazine—S100A4—cardiovascular system—metabolic syndrome X	0.00403	0.0339	CbGeAlD
Trifluoperazine—S100A4—kidney—metabolic syndrome X	0.00394	0.0332	CbGeAlD
Trifluoperazine—HTR2A—autonomic nervous system—metabolic syndrome X	0.00357	0.03	CbGeAlD
Trifluoperazine—S100A4—adipose tissue—metabolic syndrome X	0.00355	0.0299	CbGeAlD
Trifluoperazine—UGT1A4—kidney—metabolic syndrome X	0.00346	0.0291	CbGeAlD
Trifluoperazine—TNNC1—cardiovascular system—metabolic syndrome X	0.00339	0.0286	CbGeAlD
Trifluoperazine—CALM2—artery—metabolic syndrome X	0.00334	0.0281	CbGeAlD
Trifluoperazine—CALM1—artery—metabolic syndrome X	0.00332	0.028	CbGeAlD
Trifluoperazine—EBPL—liver—metabolic syndrome X	0.00316	0.0266	CbGeAlD
Trifluoperazine—EBP—liver—metabolic syndrome X	0.00303	0.0255	CbGeAlD
Trifluoperazine—TNNC1—adipose tissue—metabolic syndrome X	0.00299	0.0252	CbGeAlD
Trifluoperazine—CALM2—endothelium—metabolic syndrome X	0.00282	0.0237	CbGeAlD
Trifluoperazine—CALM1—endothelium—metabolic syndrome X	0.00281	0.0236	CbGeAlD
Trifluoperazine—CALM2—blood vessel—metabolic syndrome X	0.0026	0.0219	CbGeAlD
Trifluoperazine—CALM1—blood vessel—metabolic syndrome X	0.00259	0.0218	CbGeAlD
Trifluoperazine—XDH—kidney—metabolic syndrome X	0.00253	0.0213	CbGeAlD
Trifluoperazine—S100A4—liver—metabolic syndrome X	0.00249	0.021	CbGeAlD
Trifluoperazine—UGT1A4—liver—metabolic syndrome X	0.00219	0.0184	CbGeAlD
Trifluoperazine—HTR2A—artery—metabolic syndrome X	0.00202	0.017	CbGeAlD
Trifluoperazine—HTR2A—endothelium—metabolic syndrome X	0.00171	0.0144	CbGeAlD
Trifluoperazine—XDH—liver—metabolic syndrome X	0.0016	0.0134	CbGeAlD
Trifluoperazine—HTR2A—blood vessel—metabolic syndrome X	0.00158	0.0133	CbGeAlD
Trifluoperazine—CHRM2—cardiovascular system—metabolic syndrome X	0.00145	0.0122	CbGeAlD
Trifluoperazine—CALM3—adipose tissue—metabolic syndrome X	0.0013	0.011	CbGeAlD
Trifluoperazine—HTR1A—cardiovascular system—metabolic syndrome X	0.00118	0.00994	CbGeAlD
Trifluoperazine—SIGMAR1—adipose tissue—metabolic syndrome X	0.00116	0.0098	CbGeAlD
Trifluoperazine—CALM2—cardiovascular system—metabolic syndrome X	0.00116	0.00976	CbGeAlD
Trifluoperazine—CALM1—cardiovascular system—metabolic syndrome X	0.00115	0.00972	CbGeAlD
Trifluoperazine—CALM2—kidney—metabolic syndrome X	0.00113	0.00955	CbGeAlD
Trifluoperazine—CALM1—kidney—metabolic syndrome X	0.00113	0.00951	CbGeAlD
Trifluoperazine—ADRA1A—cardiovascular system—metabolic syndrome X	0.00109	0.00916	CbGeAlD
Trifluoperazine—Clozapine—FMO3—metabolic syndrome X	0.00108	0.129	CrCbGaD
Trifluoperazine—ABCB1—blood vessel—metabolic syndrome X	0.00103	0.0087	CbGeAlD
Trifluoperazine—CALM2—adipose tissue—metabolic syndrome X	0.00102	0.00861	CbGeAlD
Trifluoperazine—CALM1—adipose tissue—metabolic syndrome X	0.00102	0.00857	CbGeAlD
Trifluoperazine—ADRA1A—adipose tissue—metabolic syndrome X	0.000959	0.00808	CbGeAlD
Trifluoperazine—CALM3—liver—metabolic syndrome X	0.000913	0.00769	CbGeAlD
Trifluoperazine—SIGMAR1—liver—metabolic syndrome X	0.000816	0.00687	CbGeAlD
Trifluoperazine—HRH1—adipose tissue—metabolic syndrome X	0.000743	0.00625	CbGeAlD
Trifluoperazine—Antrafenine—PTGS2—metabolic syndrome X	0.000741	0.0886	CrCbGaD
Trifluoperazine—CALM2—liver—metabolic syndrome X	0.000717	0.00604	CbGeAlD
Trifluoperazine—CALM1—liver—metabolic syndrome X	0.000714	0.00601	CbGeAlD
Trifluoperazine—HTR2A—cardiovascular system—metabolic syndrome X	0.000703	0.00592	CbGeAlD
Trifluoperazine—HTR2A—kidney—metabolic syndrome X	0.000688	0.00579	CbGeAlD
Trifluoperazine—ADRA1A—liver—metabolic syndrome X	0.000673	0.00566	CbGeAlD
Trifluoperazine—Cyamemazine—HTR2C—metabolic syndrome X	0.000629	0.0752	CrCbGaD
Trifluoperazine—CYP1A2—liver—metabolic syndrome X	0.000556	0.00468	CbGeAlD
Trifluoperazine—ABCB1—cardiovascular system—metabolic syndrome X	0.000461	0.00388	CbGeAlD
Trifluoperazine—ABCB1—kidney—metabolic syndrome X	0.000451	0.0038	CbGeAlD
Trifluoperazine—Nefazodone—HTR2C—metabolic syndrome X	0.000448	0.0536	CrCbGaD
Trifluoperazine—HTR2A—liver—metabolic syndrome X	0.000435	0.00366	CbGeAlD
Trifluoperazine—Trazodone—HTR2C—metabolic syndrome X	0.000415	0.0496	CrCbGaD
Trifluoperazine—ABCB1—adipose tissue—metabolic syndrome X	0.000406	0.00342	CbGeAlD
Trifluoperazine—Thiothixene—HTR2C—metabolic syndrome X	0.000389	0.0465	CrCbGaD
Trifluoperazine—Mesoridazine—HTR2C—metabolic syndrome X	0.000384	0.0459	CrCbGaD
Trifluoperazine—Prochlorperazine—HTR2C—metabolic syndrome X	0.000371	0.0444	CrCbGaD
Trifluoperazine—Fluphenazine—HTR2C—metabolic syndrome X	0.000336	0.0402	CrCbGaD
Trifluoperazine—Propiomazine—HTR2C—metabolic syndrome X	0.000323	0.0386	CrCbGaD
Trifluoperazine—Clomipramine—HTR2C—metabolic syndrome X	0.000307	0.0367	CrCbGaD
Trifluoperazine—Thioridazine—HTR2C—metabolic syndrome X	0.000289	0.0346	CrCbGaD
Trifluoperazine—ABCB1—liver—metabolic syndrome X	0.000285	0.0024	CbGeAlD
Trifluoperazine—Methotrimeprazine—HTR2C—metabolic syndrome X	0.000276	0.033	CrCbGaD
Trifluoperazine—Loxapine—HTR2C—metabolic syndrome X	0.000267	0.0319	CrCbGaD
Trifluoperazine—Perphenazine—HTR2C—metabolic syndrome X	0.000266	0.0318	CrCbGaD
Trifluoperazine—Quetiapine—HTR2C—metabolic syndrome X	0.00026	0.0311	CrCbGaD
Trifluoperazine—Promazine—HTR2C—metabolic syndrome X	0.000239	0.0286	CrCbGaD
Trifluoperazine—Clozapine—HTR2C—metabolic syndrome X	0.000224	0.0268	CrCbGaD
Trifluoperazine—Chlorpromazine—HTR2C—metabolic syndrome X	0.000211	0.0252	CrCbGaD
Trifluoperazine—Acepromazine—ALB—metabolic syndrome X	0.000176	0.0211	CrCbGaD
Trifluoperazine—Thioproperazine—ALB—metabolic syndrome X	0.000172	0.0206	CrCbGaD
Trifluoperazine—Thiothixene—ALB—metabolic syndrome X	0.000169	0.0202	CrCbGaD
Trifluoperazine—Pipotiazine—ALB—metabolic syndrome X	0.000169	0.0202	CrCbGaD
Trifluoperazine—Clomipramine—ALB—metabolic syndrome X	0.000134	0.016	CrCbGaD
Trifluoperazine—Chlorpromazine—ALB—metabolic syndrome X	9.18e-05	0.011	CrCbGaD
Trifluoperazine—HTR2A—Signaling Pathways—APOE—metabolic syndrome X	1.17e-05	6.5e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	1.17e-05	6.5e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—APOE—metabolic syndrome X	1.17e-05	6.49e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—LEP—metabolic syndrome X	1.17e-05	6.49e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—APOE—metabolic syndrome X	1.16e-05	6.45e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—LPL—metabolic syndrome X	1.16e-05	6.44e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—INS—metabolic syndrome X	1.16e-05	6.43e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—APOA1—metabolic syndrome X	1.16e-05	6.43e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—IL6—metabolic syndrome X	1.16e-05	6.42e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—APOA1—metabolic syndrome X	1.15e-05	6.41e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—INS—metabolic syndrome X	1.15e-05	6.4e-05	CbGpPWpGaD
Trifluoperazine—XDH—Metabolism—AKT1—metabolic syndrome X	1.15e-05	6.39e-05	CbGpPWpGaD
Trifluoperazine—UGT1A4—Metabolism—AKT1—metabolic syndrome X	1.15e-05	6.39e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—APOE—metabolic syndrome X	1.15e-05	6.38e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—LEP—metabolic syndrome X	1.15e-05	6.38e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—APOA1—metabolic syndrome X	1.15e-05	6.38e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—AGT—metabolic syndrome X	1.15e-05	6.37e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—AGT—metabolic syndrome X	1.15e-05	6.37e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCL5—metabolic syndrome X	1.15e-05	6.37e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCL5—metabolic syndrome X	1.15e-05	6.37e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—INS—metabolic syndrome X	1.15e-05	6.37e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—INS—metabolic syndrome X	1.15e-05	6.37e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	1.15e-05	6.37e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	1.15e-05	6.37e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.14e-05	6.35e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.14e-05	6.35e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CCL2—metabolic syndrome X	1.14e-05	6.33e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—APOA1—metabolic syndrome X	1.14e-05	6.31e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CCL2—metabolic syndrome X	1.13e-05	6.29e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	1.13e-05	6.29e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—APOE—metabolic syndrome X	1.12e-05	6.24e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—APOE—metabolic syndrome X	1.12e-05	6.24e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—LPL—metabolic syndrome X	1.12e-05	6.23e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—LPL—metabolic syndrome X	1.12e-05	6.23e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	1.12e-05	6.22e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	1.11e-05	6.19e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—APOA1—metabolic syndrome X	1.11e-05	6.17e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—APOA1—metabolic syndrome X	1.11e-05	6.17e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—APOB—metabolic syndrome X	1.1e-05	6.11e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—SERPINE1—metabolic syndrome X	1.09e-05	6.05e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.08e-05	6.01e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	1.07e-05	5.95e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	1.07e-05	5.94e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	1.07e-05	5.94e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—AKT1—metabolic syndrome X	1.07e-05	5.93e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.06e-05	5.91e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	1.06e-05	5.89e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.06e-05	5.87e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—SERPINE1—metabolic syndrome X	1.05e-05	5.85e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—SERPINE1—metabolic syndrome X	1.05e-05	5.85e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—LPL—metabolic syndrome X	1.05e-05	5.84e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	1.04e-05	5.8e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IRS1—metabolic syndrome X	1.04e-05	5.79e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—NOS3—metabolic syndrome X	1.04e-05	5.77e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GGT1—metabolic syndrome X	1.04e-05	5.75e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GOT1—metabolic syndrome X	1.04e-05	5.75e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IRS1—metabolic syndrome X	1.03e-05	5.69e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	1.02e-05	5.68e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—INS—metabolic syndrome X	1.02e-05	5.64e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	1.02e-05	5.64e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PPARG—metabolic syndrome X	1.01e-05	5.62e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	1.01e-05	5.61e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—NOS3—metabolic syndrome X	1.01e-05	5.59e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—NOS3—metabolic syndrome X	1.01e-05	5.59e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—INS—metabolic syndrome X	1e-05	5.55e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	1e-05	5.55e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—CD36—metabolic syndrome X	9.98e-06	5.54e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—INS—metabolic syndrome X	9.98e-06	5.54e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—INS—metabolic syndrome X	9.93e-06	5.51e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AGT—metabolic syndrome X	9.92e-06	5.51e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—AKT1—metabolic syndrome X	9.87e-06	5.48e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	9.84e-06	5.46e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	9.83e-06	5.46e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—INS—metabolic syndrome X	9.82e-06	5.45e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	9.82e-06	5.45e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	9.79e-06	5.44e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PPARG—metabolic syndrome X	9.79e-06	5.44e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PPARG—metabolic syndrome X	9.79e-06	5.44e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—LEP—metabolic syndrome X	9.72e-06	5.4e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—APOE—metabolic syndrome X	9.72e-06	5.4e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	9.67e-06	5.37e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CCL2—metabolic syndrome X	9.66e-06	5.37e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	9.65e-06	5.36e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	9.63e-06	5.35e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—IL6—metabolic syndrome X	9.63e-06	5.35e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—APOA1—metabolic syndrome X	9.61e-06	5.34e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—INS—metabolic syndrome X	9.6e-06	5.33e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—INS—metabolic syndrome X	9.6e-06	5.33e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AGT—metabolic syndrome X	9.59e-06	5.33e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AGT—metabolic syndrome X	9.59e-06	5.33e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—AKT1—metabolic syndrome X	9.55e-06	5.3e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—AKT1—metabolic syndrome X	9.55e-06	5.3e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PTGS2—metabolic syndrome X	9.51e-06	5.28e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IGF1—metabolic syndrome X	9.5e-06	5.27e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	9.47e-06	5.26e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—APOE—metabolic syndrome X	9.4e-06	5.22e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—LEP—metabolic syndrome X	9.4e-06	5.22e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—APOE—metabolic syndrome X	9.4e-06	5.22e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—LEP—metabolic syndrome X	9.4e-06	5.22e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	9.34e-06	5.18e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—IL6—metabolic syndrome X	9.32e-06	5.18e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—IL6—metabolic syndrome X	9.32e-06	5.18e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—APOA1—metabolic syndrome X	9.29e-06	5.16e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—APOA1—metabolic syndrome X	9.29e-06	5.16e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PPARA—metabolic syndrome X	9.28e-06	5.15e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PTGS2—metabolic syndrome X	9.2e-06	5.11e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PTGS2—metabolic syndrome X	9.2e-06	5.11e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	9.19e-06	5.1e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	9.17e-06	5.09e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—ALB—metabolic syndrome X	9.1e-06	5.06e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TGFB1—metabolic syndrome X	9.07e-06	5.04e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—SERPINE1—metabolic syndrome X	9.02e-06	5.01e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	8.99e-06	5e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—AGT—metabolic syndrome X	8.99e-06	4.99e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	8.91e-06	4.95e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—AKT1—metabolic syndrome X	8.89e-06	4.94e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—APOE—metabolic syndrome X	8.81e-06	4.89e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—ALB—metabolic syndrome X	8.8e-06	4.89e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—ALB—metabolic syndrome X	8.8e-06	4.89e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—APOB—metabolic syndrome X	8.78e-06	4.88e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	8.77e-06	4.87e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	8.75e-06	4.86e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—NOS3—metabolic syndrome X	8.71e-06	4.84e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—APOA1—metabolic syndrome X	8.71e-06	4.84e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.7e-06	4.83e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IRS1—metabolic syndrome X	8.67e-06	4.81e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	8.65e-06	4.81e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—NOS3—metabolic syndrome X	8.61e-06	4.78e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—AKT1—metabolic syndrome X	8.6e-06	4.77e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—AKT1—metabolic syndrome X	8.6e-06	4.77e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	8.59e-06	4.77e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	8.56e-06	4.76e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	8.55e-06	4.75e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—AKT1—metabolic syndrome X	8.53e-06	4.74e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	8.52e-06	4.73e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—NOS3—metabolic syndrome X	8.42e-06	4.68e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—NOS3—metabolic syndrome X	8.42e-06	4.68e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—LPL—metabolic syndrome X	8.39e-06	4.66e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IRS1—metabolic syndrome X	8.39e-06	4.66e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IRS1—metabolic syndrome X	8.39e-06	4.66e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—INS—metabolic syndrome X	8.3e-06	4.61e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—AKT1—metabolic syndrome X	8.26e-06	4.58e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—AKT1—metabolic syndrome X	8.26e-06	4.58e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCL2—metabolic syndrome X	8.17e-06	4.54e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—INS—metabolic syndrome X	8.03e-06	4.46e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—INS—metabolic syndrome X	8.03e-06	4.46e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IGF1—metabolic syndrome X	8.03e-06	4.46e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CD36—metabolic syndrome X	7.97e-06	4.43e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PTGS2—metabolic syndrome X	7.96e-06	4.42e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCL2—metabolic syndrome X	7.9e-06	4.39e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCL2—metabolic syndrome X	7.9e-06	4.39e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	7.9e-06	4.39e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	7.86e-06	4.36e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IGF1—metabolic syndrome X	7.77e-06	4.31e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IGF1—metabolic syndrome X	7.77e-06	4.31e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PTGS2—metabolic syndrome X	7.7e-06	4.28e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PTGS2—metabolic syndrome X	7.7e-06	4.28e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PPARG—metabolic syndrome X	7.67e-06	4.26e-05	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	7.64e-06	4.24e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—SERPINE1—metabolic syndrome X	7.63e-06	4.23e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—INS—metabolic syndrome X	7.52e-06	4.18e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	7.52e-06	4.18e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.52e-06	4.17e-05	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	7.5e-06	4.16e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PPARA—metabolic syndrome X	7.41e-06	4.12e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	7.4e-06	4.11e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	7.38e-06	4.1e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—AKT1—metabolic syndrome X	7.38e-06	4.1e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SERPINE1—metabolic syndrome X	7.38e-06	4.1e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SERPINE1—metabolic syndrome X	7.38e-06	4.1e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.36e-06	4.09e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NOS3—metabolic syndrome X	7.28e-06	4.04e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—IL6—metabolic syndrome X	7.26e-06	4.03e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	7.24e-06	4.02e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AGT—metabolic syndrome X	7.18e-06	3.99e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NOS3—metabolic syndrome X	7.04e-06	3.91e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NOS3—metabolic syndrome X	7.04e-06	3.91e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—APOE—metabolic syndrome X	7.03e-06	3.9e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—APOA1—metabolic syndrome X	6.95e-06	3.86e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	6.94e-06	3.85e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—ALB—metabolic syndrome X	6.9e-06	3.83e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—TGFB1—metabolic syndrome X	6.87e-06	3.82e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL6—metabolic syndrome X	6.83e-06	3.8e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	6.82e-06	3.79e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	6.81e-06	3.78e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	6.71e-06	3.73e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—AKT1—metabolic syndrome X	6.7e-06	3.72e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	6.68e-06	3.71e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	6.68e-06	3.71e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—TGFB1—metabolic syndrome X	6.65e-06	3.69e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—TGFB1—metabolic syndrome X	6.65e-06	3.69e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—NOS3—metabolic syndrome X	6.6e-06	3.66e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—AKT1—metabolic syndrome X	6.3e-06	3.5e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL6—metabolic syndrome X	6.14e-06	3.41e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PPARG—metabolic syndrome X	6.12e-06	3.4e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTGS2—metabolic syndrome X	6.03e-06	3.35e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—INS—metabolic syndrome X	6.01e-06	3.34e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL6—metabolic syndrome X	5.94e-06	3.3e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL6—metabolic syndrome X	5.94e-06	3.3e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	5.89e-06	3.27e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	5.8e-06	3.22e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	5.79e-06	3.21e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TGFB1—metabolic syndrome X	5.69e-06	3.16e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	5.68e-06	3.15e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—AKT1—metabolic syndrome X	5.66e-06	3.15e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL6—metabolic syndrome X	5.61e-06	3.12e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ALB—metabolic syndrome X	5.51e-06	3.06e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—AKT1—metabolic syndrome X	5.48e-06	3.04e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—AKT1—metabolic syndrome X	5.48e-06	3.04e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL6—metabolic syndrome X	5.43e-06	3.01e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL6—metabolic syndrome X	5.43e-06	3.01e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—NOS3—metabolic syndrome X	5.27e-06	2.93e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IL6—metabolic syndrome X	5.18e-06	2.88e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—AKT1—metabolic syndrome X	5.18e-06	2.87e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	5.06e-06	2.81e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	5.03e-06	2.79e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IL6—metabolic syndrome X	5.01e-06	2.78e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IL6—metabolic syndrome X	5.01e-06	2.78e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—AKT1—metabolic syndrome X	5.01e-06	2.78e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—AKT1—metabolic syndrome X	5.01e-06	2.78e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	4.82e-06	2.68e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TGFB1—metabolic syndrome X	4.81e-06	2.67e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—AKT1—metabolic syndrome X	4.78e-06	2.65e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	4.67e-06	2.59e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TGFB1—metabolic syndrome X	4.66e-06	2.59e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TGFB1—metabolic syndrome X	4.66e-06	2.59e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	4.64e-06	2.58e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—AKT1—metabolic syndrome X	4.62e-06	2.57e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—AKT1—metabolic syndrome X	4.62e-06	2.57e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL6—metabolic syndrome X	4.44e-06	2.47e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	4.37e-06	2.43e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL6—metabolic syndrome X	4.36e-06	2.42e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL6—metabolic syndrome X	4.29e-06	2.38e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	4.28e-06	2.38e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	4.1e-06	2.28e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	4.03e-06	2.24e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	4.02e-06	2.23e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—AKT1—metabolic syndrome X	4e-06	2.22e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—AKT1—metabolic syndrome X	3.96e-06	2.2e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	3.95e-06	2.19e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—AKT1—metabolic syndrome X	3.87e-06	2.15e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—AKT1—metabolic syndrome X	3.87e-06	2.15e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL6—metabolic syndrome X	3.63e-06	2.01e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL6—metabolic syndrome X	3.51e-06	1.95e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL6—metabolic syndrome X	3.51e-06	1.95e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AKT1—metabolic syndrome X	3.35e-06	1.86e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AKT1—metabolic syndrome X	3.24e-06	1.8e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AKT1—metabolic syndrome X	3.24e-06	1.8e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—AKT1—metabolic syndrome X	3.03e-06	1.68e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AKT1—metabolic syndrome X	2.42e-06	1.34e-05	CbGpPWpGaD
